Clinical trial
Long-term Outcomes of CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
NCT06195085 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Outcomes of CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2013
- Completion date
- July 1, 2023
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brachytherapy, desmoid tumor, radioactive iodine-125 seed implantation